Cargando…
Recombinant Human FSH Treatment Outcomes in Five Boys With Severe Congenital Hypogonadotropic Hypogonadism
CONTEXT: Recombinant human FSH (r-hFSH), given to prepubertal boys with hypogonadotropic hypogonadism (HH), may induce Sertoli cell proliferation and thereby increase sperm-producing capacity later in life. OBJECTIVE: To evaluate the effects of r-hFSH, human chorionic gonadotropin (hCG), and testost...
Autores principales: | Kohva, Ella, Huopio, Hanna, Hero, Matti, Miettinen, Päivi J, Vaaralahti, Kirsi, Sidoroff, Virpi, Toppari, Jorma, Raivio, Taneli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6270974/ https://www.ncbi.nlm.nih.gov/pubmed/30519672 http://dx.doi.org/10.1210/js.2018-00225 |
Ejemplares similares
-
MON-246 Long-Term Impact of Recombinant Follicle Stimulating Hormone Treatment in Five Infants with Hypogonadotropic Hypogonadism
por: Kohva, Ella, et al.
Publicado: (2019) -
Treatment of gonadotropin deficiency during the first year of life: long-term observation and outcome in five boys
por: Kohva, Ella, et al.
Publicado: (2019) -
Reversible Congenital Hypogonadotropic Hypogonadism in Patients with CHD7, FGFR1 or GNRHR Mutations
por: Laitinen, Eeva-Maria, et al.
Publicado: (2012) -
Circulating Liver-enriched Antimicrobial Peptide-2 Decreases During Male Puberty
por: Varimo, Tero, et al.
Publicado: (2022) -
Screening for mutations in selected miRNA genes in hypogonadotropic hypogonadism patients
por: Iivonen, Anna-Pauliina, et al.
Publicado: (2019)